BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 22509028)

  • 1. BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain.
    Devaiah BN; Lewis BA; Cherman N; Hewitt MC; Albrecht BK; Robey PG; Ozato K; Sims RJ; Singer DS
    Proc Natl Acad Sci U S A; 2012 May; 109(18):6927-32. PubMed ID: 22509028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intrinsic kinase activity of BRD4 spans its BD2-B-BID domains.
    Weissman JD; Singh AK; Devaiah BN; Schuck P; LaRue RC; Singer DS
    J Biol Chem; 2021 Nov; 297(5):101326. PubMed ID: 34688663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-talk among RNA polymerase II kinases modulates C-terminal domain phosphorylation.
    Devaiah BN; Singer DS
    J Biol Chem; 2012 Nov; 287(46):38755-66. PubMed ID: 23027873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brd4 activates P-TEFb for RNA polymerase II CTD phosphorylation.
    Itzen F; Greifenberg AK; Bösken CA; Geyer M
    Nucleic Acids Res; 2014 Jul; 42(12):7577-90. PubMed ID: 24860166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splicing and transcription-associated proteins PSF and p54nrb/nonO bind to the RNA polymerase II CTD.
    Emili A; Shales M; McCracken S; Xie W; Tucker PW; Kobayashi R; Blencowe BJ; Ingles CJ
    RNA; 2002 Sep; 8(9):1102-11. PubMed ID: 12358429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells.
    Zhang W; Prakash C; Sum C; Gong Y; Li Y; Kwok JJ; Thiessen N; Pettersson S; Jones SJ; Knapp S; Yang H; Chin KC
    J Biol Chem; 2012 Dec; 287(51):43137-55. PubMed ID: 23086925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative interaction of transcription termination factors with the RNA polymerase II C-terminal domain.
    Lunde BM; Reichow SL; Kim M; Suh H; Leeper TC; Yang F; Mutschler H; Buratowski S; Meinhart A; Varani G
    Nat Struct Mol Biol; 2010 Oct; 17(10):1195-201. PubMed ID: 20818393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromodomain 4: a cellular Swiss army knife.
    Devaiah BN; Gegonne A; Singer DS
    J Leukoc Biol; 2016 Oct; 100(4):679-686. PubMed ID: 27450555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting.
    Wu SY; Lee AY; Lai HT; Zhang H; Chiang CM
    Mol Cell; 2013 Mar; 49(5):843-57. PubMed ID: 23317504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29.
    Zhou M; Huang K; Jung KJ; Cho WK; Klase Z; Kashanchi F; Pise-Masison CA; Brady JN
    J Virol; 2009 Jan; 83(2):1036-44. PubMed ID: 18971272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRD4 bimodal binding at promoters and drug-induced displacement at Pol II pause sites associates with I-BET sensitivity.
    Khoueiry P; Ward Gahlawat A; Petretich M; Michon AM; Simola D; Lam E; Furlong EE; Benes V; Dawson MA; Prinjha RK; Drewes G; Grandi P
    Epigenetics Chromatin; 2019 Jul; 12(1):39. PubMed ID: 31266503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics studies of the interactome of RNA polymerase II C-terminal repeated domain.
    Pineda G; Shen Z; de Albuquerque CP; Reynoso E; Chen J; Tu CC; Tang W; Briggs S; Zhou H; Wang JY
    BMC Res Notes; 2015 Oct; 8():616. PubMed ID: 26515650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-TEFb-mediated phosphorylation of hSpt5 C-terminal repeats is critical for processive transcription elongation.
    Yamada T; Yamaguchi Y; Inukai N; Okamoto S; Mura T; Handa H
    Mol Cell; 2006 Jan; 21(2):227-37. PubMed ID: 16427012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct Roles of Brd2 and Brd4 in Potentiating the Transcriptional Program for Th17 Cell Differentiation.
    Cheung KL; Zhang F; Jaganathan A; Sharma R; Zhang Q; Konuma T; Shen T; Lee JY; Ren C; Chen CH; Lu G; Olson MR; Zhang W; Kaplan MH; Littman DR; Walsh MJ; Xiong H; Zeng L; Zhou MM
    Mol Cell; 2017 Mar; 65(6):1068-1080.e5. PubMed ID: 28262505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription.
    Jang MK; Mochizuki K; Zhou M; Jeong HS; Brady JN; Ozato K
    Mol Cell; 2005 Aug; 19(4):523-34. PubMed ID: 16109376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review on kinases phosphorylating the carboxyl-terminal domain of RNA polymerase II-Biological functions and inhibitors.
    Zhang J; Zhang X; Huang H; Ding Y
    Bioorg Chem; 2020 Nov; 104():104318. PubMed ID: 33142427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cdc15 Phosphorylates the C-terminal Domain of RNA Polymerase II for Transcription during Mitosis.
    Singh AK; Rastogi S; Shukla H; Asalam M; Rath SK; Akhtar MS
    J Biol Chem; 2017 Mar; 292(13):5507-5518. PubMed ID: 28202544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein.
    Bartholomeeusen K; Xiang Y; Fujinaga K; Peterlin BM
    J Biol Chem; 2012 Oct; 287(43):36609-16. PubMed ID: 22952229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine-7 but not serine-5 phosphorylation primes RNA polymerase II CTD for P-TEFb recognition.
    Czudnochowski N; Bösken CA; Geyer M
    Nat Commun; 2012 May; 3():842. PubMed ID: 22588304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.
    Gomes NP; Bjerke G; Llorente B; Szostek SA; Emerson BM; Espinosa JM
    Genes Dev; 2006 Mar; 20(5):601-12. PubMed ID: 16510875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.